Follow on Study From RE-ALIGN



Status:Recruiting
Conditions:Cardiology
Therapuetic Areas:Cardiology / Vascular Diseases
Healthy:No
Age Range:Any
Updated:11/11/2012
Start Date:December 2011
Contact:Boehringer Ingelheim Call Center
Email:clintriage.rdg@boehringer-ingelheim.com
Phone:1-800-243-0127

Use our guide to learn which trials are right for you!

Evaluation of the Long Term Safety of the Use of Dabigatran Etexilate in Patients With a Bileaflet Mechanical Heart Valve


To collect additional data relating to safety and indicators of efficacy for patients who
have participated in the 1160.113 study.


Inclusion criteria:

1. Completed study 1160.113 per protocol

2. Continuing need for anticoagulation

Exclusion criteria:

1. uncontrolled hypertension

2. severe renal impairment

3. active liver disease

4. increased risk of bleeding
We found this trial at
6
sites
?
mi
from
Durham, NC
Click here to add this to my saved trials
?
mi
from
Albuquerque, NM
Click here to add this to my saved trials
Philadelphia, Pennsylvania
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
?
mi
from
Plano, TX
Click here to add this to my saved trials
?
mi
from
Rochester, MN
Click here to add this to my saved trials
?
mi
from
Tacoma, WA
Click here to add this to my saved trials